China Resources and others have established a pharmaceutical industry equity investment fund in Chengdu with a capital contribution of 1 billion yuan.

Tianyancha business information shows that recently, China Resources Pharmaceutical Industry Equity Investment Fund Limited Partnership was established, with China Resources Medical Technology Partnership as the executive affairs partner. The capital contribution is 1 billion RMB, with a business scope of venture capital. The partners of the fund include Chengdu Major Industrialization Project Phase II Equity Investment Fund Limited Company, Boya Biotech, Dong'e Ejiao, China Resources Double-Crane, Jiang Zhong Pharmaceutical Industry, and others. According to media reports, in July of this year, several listed companies under China Resources announced that they would jointly invest with Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. and Chengdu State-owned Enterprises to establish China Resources Pharmaceutical Innovation Investment Fund Partnership, focusing on the pharmaceutical and health industry, as well as strategic emerging industries.